Clinical Trials Browser

Phase 2 × MLN 8237 × Genitourinary × Clear all

NCT02109328 2019-04-11

Alisertib in Chemotherapy-pretreated Urothelial Cancer

Phase 2 Completed

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell

NCT01799278 2018-01-23

A Phase II Trial of MLN8237 in Patients With Metastatic Castrate Resistant and Neuroendocrine Prostate Cancer

Phase 2 Completed

60 enrolled 10 charts

Prostatic Neoplasms